Smokers and diabetics might be at a heightened risk for developing hippocampal calcifications—abnormal buildups triggered by vascular disease—according to a Radiology study published this week.

A noninvasive imaging technique combined with fractional flow reserve (FFR) showed the potential to detect functionally significant lesions in patients with multivessel coronary artery disease (CAD), according to a study published June 11 in the Journal of the American College of Cardiology.

Fewer Americans are receiving radiotherapy during their first course of cancer treatment than a decade ago, a trio of researchers reported in the Journal of the American College of Radiology this month—and more are turning to systemic therapy as an alternative.

Partial breast irradiation, though an attractive alternative to whole-breast radiotherapy, is prone to movement changes of around 4 millimeters during imaging, according to research out of the Netherlands Cancer Institute in Amsterdam. That finding suggests physicians might want to take extra steps to ensure image quality and avoid unnecessary radiation.

Despite claims otherwise from President Donald Trump, the Affordable Care Act remains the law of the land—though federal actions have increased instability in the ACA’s marketplaces. Following last year’s repeal of the individual mandate, insurers are now offering short-term, non-ACA-compliant policies, which could leave a sicker, older population shopping on ACA marketplaces.

Officials from HHS are currently talking with pharmaceutical companies to pursue voluntary price cuts as part of President Donald Trump’s drug pricing plan, The Hill reports.

A Boston-area cardiologist and an advocate against nuclear weapons met with North Korean diplomats ahead of the 2018 United States-North Korea Summit in Singapore, reports WFXT, the FOX affiliate in Boston.

Boston Scientific said Monday it won't comment on reports rival medical device manufacturer Stryker made a takeover bid. The news was first reported by The Wall Street Journal. Stryker also stated it does not comment on potential mergers or acquisitions.